Sedating a patient Chat friends american los angeles

Posted by / 17-Jun-2020 16:19

Sedation also is an essential therapeutic component of intracranial pressure therapy, targeted temperature management and seizure control.

intracranial pressure elevation) and the potential benefits of enhanced neurological function and reduced complications.Therefore, whether the new paradigm of minimal sedation can be translated to the neuro-ICU (NICU) is unclear.In patients with ABI, sedation has ‘general’ indications (control of anxiety, pain, discomfort, agitation, facilitation of mechanical ventilation) and ‘neuro-specific’ indications (reduction of cerebral metabolic demand, improved brain tolerance to ischaemia).CBF reduction is an adaptive phenomenon to diminished brain metabolism.While sedatives exert a coupled reduction of CBF/CMRO, they often have systemic haemodynamic side effects, by decreasing mean arterial blood pressure (MAP) and also by inducing myocardial depression and peripheral vasodilatation.

sedating a patient-16sedating a patient-67sedating a patient-60

Whether a strategy of avoiding sedation is applicable to neurointensive care is unknown: this must be balanced between the potential benefit that daily interruption of sedation might have on enhancing awakening and monitoring of neurological function and the risk that stopping sedatives (hypnotics) and analgesics (opioids) might exacerbate intracranial hypertension in patients with reduced brain compliance.